Nanocarrier drug resistant tumor interactions: novel approaches to fight drug resistance in cancer

Abstract

Cancer is one of the biggest healthcare concerns in our century, a disease whose treatment has become even more difficult following reports of drug-resistant tumors. When this happens, chemotherapy treatments fail or decrease in efficiency, leading to catastrophic consequences to the patient. This discovery, along with the fact that drug resistance limits the efficacy of current treatments, has led to a new wave of discovery for new methods of treatment. The use of nanomedicine has been widely studied in current years as a way to effectively fight drug resistance in cancer. Research in the area of cancer nanotechnology over the past decades has led to tremendous advancement in the synthesis of tailored nanoparticles with targeting ligands that can successfully attach to chemotherapy-resistant cancer by preferentially accumulating within the tumor region through means of active and passive targeting. Consequently, these approaches can reduce the off-target accumulation of their payload and lead to reduced cytotoxicity and better targeting. This review explores some categories of nanocarriers that have been used in the treatment of drug-resistant cancers, including polymeric, viral, lipid-based, metal-based, carbon-based, and magnetic nanocarriers, opening the door for an exciting field of discovery that holds tremendous promise in the treatment of these tumors.

Keywords

Drug-resistance / cancer / nanotechnology / nanocarriers / drug delivery

References

[1] Sarkar S,Moulton K.Cancer development, progression, and therapy: an epigenetic overview..Int J Mol Sci2013;14:21087-113 PMCID:PMC3821660

[2] Siegel RL,Jemal A.Cancer statistics, 2020..CA Cancer J Clin2020;70:7-30

[3] Greenivald P.Landmarks in the history of cancer epidemiology..Cancer Res2009;69:2151-62

[4] Van der Meel R,Shi Y.Smart cancer nanomedicine..Nat Nanotechnol2019;14:1007-17 PMCID:PMC7227032

[5] Chen H,Zhu G,Chen X.Rethinking cancer nanotheranostics..Nat Rev Mater2017;2:1-18 PMCID:PMC5654564

[6] Lippert TH,Volm M.Intrinsic and acquired drug resistance in malignant tumors: The main reason for therapeutic failure..Arzneimittelforschung2008;58:261-4

[7] Housman G,Heerboth S.Drug resistance in cancer: an overview..Cancers (Basel)2014;6:1769-92 PMCID:PMC4190567

[8] Gottesman MM.Mechanisms of cancer drug resistance..Annu Rev Med2002;53:615-27

[9] Yang J,Liu W.Microtubule-associated protein tau is associated with the resistance to docetaxel in prostate cancer cell lines..Res Rep Urol2017;9:71-7 PMCID:PMC5428793

[10] Pan ST,He ZX,Zhou SF.Molecular mechanisms for tumour resistance to chemotherapy..Clin Exp Pharmacol Physiol2016;43:723-37

[11] Kalal BS,Pai VR.Chemotherapy resistance mechanisms in advanced skin cancer..Oncol Rev2017;11:19-25 PMCID:PMC5379221

[12] Suzawa K,Schoenfeld AJ.Acquired MET Exon 14 alteration drives secondary resistance to epidermal growth factor receptor tyrosine kinase inhibitor in EGFR -mutated lung cancer..JCO Precis Oncol2019;3:1-8 PMCID:PMC6541452

[13] Robey RW,Hall MD.Revisiting the role of ABC transporters in multidrug-resistant cancer..Nat Rev Cancer2018;18:452-64 PMCID:PMC6622180

[14] Hermawan A,Roidl A.Consecutive salinomycin treatment reduces doxorubicin resistance of breast tumor cells by diminishing drug efflux pump expression and activity..Oncol Rep2016;35:1732-40

[15] Hu T,Gao CY.Mechanisms of drug resistance in colon cancer and its therapeutic strategies..World J Gastroenterol2016;22:6876-89 PMCID:PMC4974586

[16] Kim SJ,Kim DW.Alterations in PD-L1 expression associated with acquisition of resistance to ALK inhibitors in ALK-rearranged lung cancer..Cancer Res Treat2019;51:1231-40 PMCID:PMC6639241

[17] Toth RK,Muldong MT.Hypoxia-induced PIM kinase and laminin-activated integrin $α$6 mediate resistance to PI3K inhibitors in bone-metastatic CRPC..Am J Clin Exp Urol2019;7:297-312 PMCID:PMC6734039

[18] Wang S,Zhu J.DNA repair genes ERCC1 and BRCA1 expression in non-small cell lung cancer chemotherapy drug resistance..Med Sci Monit2016;22:1999-2005 PMCID:PMC4913815

[19] Nogales V,Varma S.Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs..Oncotarget2016;7:3084-97 PMCID:PMC4823092

[20] Dagogo-Jack I.Tumour heterogeneity and resistance to cancer therapies..Nat Rev Clin Oncol2018;15:81-94

[21] Russo M,Blaszkowsky LS.Tumor heterogeneity and Lesion-Specific response to targeted therapy in colorectal cancer..Cancer Discov2016;6:147-53 PMCID:PMC4744519

[22] Mansoori B,Davudian S,Baradaran B.The different mechanisms of cancer drug resistance: a brief review..Adv Pharm Bull2017;7:339-48 PMCID:PMC5651054

[23] Du B.Targeting epithelial-mesenchymal transition (EMT) to overcome drug resistance in cancer..Molecules2016;21:965 PMCID:PMC6273543

[24] Elaskalani O,Falasca M.Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer..World J Gastrointestinal Oncol2017;9:37-41 PMCID:PMC5241525

[25] Islam SU,Sonn JK.PRPF overexpression induces drug resistance through actin cytoskeleton rearrangement and epithelial-mesenchymal transition..Oncotarget2017;8:56659-71 PMCID:PMC5593591

[26] Gao M,Liu F.Triggered ferroptotic polymer micelles for reversing multidrug resistance to chemotherapy..Biomaterials2019;223:119486

[27] Tran S,Piel B.Cancer nanomedicine: a review of recent success in drug delivery..Clin Transl Med2017;6:44 PMCID:PMC5725398

[28] Xin Y,Zhao L,Luo L.Recent progress on nanoparticle-based drug delivery systems for cancer therapy..Cancer Biol Med2017;14:228-41 PMCID:PMC5570600

[29] Truong NP,Mak CW.The importance of nanoparticle shape in cancer drug delivery..Expert Opin Drug Del2015;12:129-42

[30] Li Z,Li S,Wang K.Cancer drug delivery in the nano era: an overview and perspectives (Review)..Oncol Rep2017;38:611-24 PMCID:PMC5562049

[31] Din FU,Ullah I.Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors..Int J Nanomedicine2017;12:7291-309 PMCID:PMC5634382

[32] Kesharwani SS,Tummala H.Multifunctional approaches utilizing polymeric micelles to circumvent multidrug resistant tumors..Colloids Surfaces B Biointerfaces2019;173:581-90

[33] Raveendran R.Sharma CP.Chapter 12 - Polymeric micelles: Smart nanocarriers for anticancer drug delivery..Drug Delivery Nanosystems for Biomedical Applications.2018;Elsevier255-73

[34] Yang X,Tan Y.Selective uptake of chitosan polymeric micelles by circulating monocytes for enhanced tumor targeting..Carbohydr Polym2020;229:115435

[35] Yao Q,Kou L.Tumor-targeted drug delivery and sensitization by MMP2-responsive polymeric micelles..Nanomedicine2019;19:71-80 PMCID:PMC6599579

[36] Zhen S,Zhao Z.Drug delivery micelles with efficient near-infrared photosensitizer for combined image-guided photodynamic therapy and chemotherapy of drug-resistant cancer..Biomaterials2019;218:119330

[37] Ambekar RS,Kandasubramanian B.Recent advances in dendrimer-based nanoplatform for cancer treatment: a review..Eur Polym J2020;126:109546

[38] Choudhary S,Rani S,Gupta U.Impact of dendrimers on solubility of hydrophobic drug molecules..Front Pharmacol2017;8:261 PMCID:PMC5432624

[39] Rajani C,Karanwad T.Chauhan A.7 - Cancer-targeted chemotherapy: Emerging role of the folate anchored dendrimer as drug delivery nanocarrier..Pharmaceutical Applications of Dendrimers.2020;Elsevier151-98

[40] Siriviriyanun A,Voon SH.Cyclodextrin- and dendrimer-conjugated graphene oxide as a nanocarrier for the delivery of selected chemotherapeutic and photosensitizing agents..Mater Sci Eng C2018;89:307-15

[41] Golshan M,Mirshekarpour M,Mohammadi M.Synthesis and characterization of poly(propylene imine)-dendrimer-grafted gold nanoparticles as nanocarriers of doxorubicin..Colloids Surfaces B Biointerfaces2017;155:257-65

[42] Fan Y,Huo M.Spatial controlled multistage nanocarriers through hybridization of dendrimers and gelatin nanoparticles for deep penetration and therapy into tumor tissue..Nanomedicine2017;13:1399-410

[43] Rompicharla SVK,Bhatt H,Biswas S.Biotin functionalized PEGylated poly(amidoamine) dendrimer conjugate for active targeting of paclitaxel in cancer..Int J Pharm2019;557:329-41

[44] Liang S,Yang P.Core-shell structured upconversion nanocrystal-dendrimer composite as a carrier for mitochondria targeting and catalase enhanced anti-cancer photodynamic therapy..Biomaterials2020;240:119850

[45] Pan J,Yao M.Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance..Eur J Pharm Biopharm2019;136:18-28 PMCID:PMC6377860

[46] Gouveia M,Jardim MG.Poly(alkylidenimine) dendrimers functionalized with the organometallicmoiety [Ru(ν 5-C5H5)(PPh3)2]+ as promising drugs against cisplatin-resistant cancer cells and humanmesenchymal stem cells..Molecules2018;23:1471 PMCID:PMC6100097

[47] Messager L,Chierico L.Novel aspects of encapsulation and delivery using polymersomes..Curr Opin Pharmacol2014;18:104-11

[48] Dan N.Grumezescu AM.Chapter 1 - vesicle-based drug carriers: liposomes, polymersomes, and niosomes..Design and Development of New Nanocarriers.2018;William Andrew Publishing1-55

[49] Khan MA,Venkatraman SS.Fabrication of poly (butadiene-block-ethylene oxide) based amphiphilic polymersomes: an approach for improved oral pharmacokinetics of Sorafenib..Int J Pharm2018;542:196-204

[50] Köthe T,Reich G.Dual asymmetric centrifugation as a novel method to prepare highly concentrated dispersions of PEG-b-PCL polymersomes as drug carriers..Int J Pharm2020;579:119087

[51] Liu Q,Chen S.A superparamagnetic polymersome with extremely high T2 relaxivity for MRI and cancer-targeted drug delivery..Biomaterials2017;114:23-33

[52] Zhu D,Hu C.Folate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinoma..Acta Biomater2017;58:399-412

[53] Zavvar T,Abnous K.Synthesis of multimodal polymersomes for targeted drug delivery and MR/fluorescence imaging in metastatic breast cancer model..Int J Pharm2020;578:119091

[54] Simón-Gracia L,Scodeller PD.Paclitaxel-loaded polymersomes for enhanced intraperitoneal chemotherapy..Mol Cancer Ther2016;15:670 PMCID:PMC4873343

[55] Alibolandi M,Abnous K.AS1411 aptamer-decorated biodegradable polyethylene glycol-poly(lactic-co-glycolic acid) nanopolymersomes for the targeted delivery of gemcitabine to non-small cell lung cancer in vitro..J Pharm Sci2016;105:1741-50

[56] Alibolandi M,Hadizadeh F.Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo..J Control Release2016;241:45-56

[57] Qin Y,Huang C.Folate-targeted redox-responsive polymersomes loaded with chemotherapeutic drugs and tariquidar to overcome drug resistance..J Biomed Nanotechnol2018;14:1705-18

[58] Franke CE,Patel RB.Tobacco mosaic virus-delivered cisplatin restores efficacy in platinum-resistant ovarian cancer cells..Mol Pharm2018;15:2922-31

[59] Perillo E,Falanga A.Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines..Oncotarget2016;7:4077-92 PMCID:PMC4826191

[60] Bell J.Viruses for tumor therapy..Cell Host Microbe2014;15:260-5 PMCID:PMC3963258

[61] Hou W,Rojas JJ.Oncolytic virus-mediated targeting of PGE2 in the tumor alters the immune status and sensitizes established and resistant tumors to immunotherapy..Cancer Cell2016;30:108-19 PMCID:PMC4962335

[62] Mahoney DJ,Allan K.Virus-Tumor interactome screen reveals ER stress response can reprogram resistant cancers for oncolytic virus-triggered caspase-2 cell death..Cancer Cell2011;20:443-56

[63] Muscolini M,Palermo E.SIRT1 modulates the sensitivity of prostate cancer cells to vesicular stomatitis virus oncolysis..J Virol2019;93:e00626-19 PMCID:PMC6639275

[64] Dold C,Wollmann G.Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy..Mol Ther Oncolytics2016;3:16021 PMCID:PMC5040171

[65] Martikainen M,von und zu Fraunberg M.MicroRNA-attenuated clone of virulent semliki forest virus overcomes antiviral type i interferon in resistant mouse CT-2A glioma..J Virol2015;89:10637-47 PMCID:PMC4580204

[66] Subramani T.An overview of liposomal nano-encapsulation techniques and its applications in food and nutraceutical..J Food Sci Technol2020;57:3545-55 PMCID:PMC7447741

[67] Mehta PP,Pawar AP,Dhapte-Pawar VS.Recent advances in inhalable liposomes for treatment of pulmonary diseases: concept to clinical stance..J Drug Deliv Sci Technol2020;56:101509

[68] Hossen S,Basher MK.Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: a review..J Adv Res2019;15:1-18 PMCID:PMC6300464

[69] Jampílek J.Grumezescu AM.Chapter 8 - recent advances in lipid nanocarriers applicable in the fight against cancer..Nanoarchitectonics in Biomedicine.2019;William Andrew Publishing219-94

[70] Chauhan SB.Recent advances in liposome..Res J Pharm Technol2020;13:2053-8

[71] Kiaie N,Penson PE.A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome..Drug Discov Today2020;25:58-72

[72] Sercombe L,Moheimani F.Advances and challenges of liposome assisted drug delivery..Front Pharmacol2015;6:286 PMCID:PMC4664963

[73] Crommelin DJA,Storm G.The role of liposomes in clinical nanomedicine development. What now? Now what?.J Control Release2020;318:256-63

[74] Paliwal SR,Agrawal GP.Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin..J Liposome Res2016;26:276-87

[75] Chen M,Liu Y.A dual pH-sensitive liposomal system with charge-reversal and NO generation for overcoming multidrug resistance in cancer..Nanoscale2019;11:3814-26

[76] Feng X,Jiang H.Dihydroartemisinin potentiates the anticancer effect of cisplatin via mTOR inhibition in cisplatin-resistant ovarian cancer cells: involvement of apoptosis and autophagy..Biochem Biophys Res Commun2014;444:376-81

[77] Qiu L,Xu Y.Enhanced combination therapy effect on paclitaxel-resistant carcinoma by chloroquine co-delivery via liposomes..Int J Nanomedicine2015;10:6615 PMCID:PMC4622487

[78] Kang XJ,Peng HG.Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy..Acta Pharmacol Sin2017;38:885-96 PMCID:PMC5520183

[79] Li N,Liu Q,Yang J.Docetaxel-loaded D-α-tocopheryl polyethylene glycol-1000 succinate liposomes improve lung cancer chemotherapy and reverse multidrug resistance..Drug Deliv Transl Res2020;doi: 10.1007/s13346-020-00720-9

[80] Shen Q,Jin F,Ying X.Paclitaxel/hydroxypropyl-β-cyclodextrin complex-loaded liposomes for overcoming multidrug resistance in cancer chemotherapy..J Liposome Res2020;30:12-20

[81] Li X,Yang H.A nuclear targeted Dox-aptamer loaded liposome delivery platform for the circumvention of drug resistance in breast cancer..Biomed Pharmacother2019;117:109072

[82] Nasirizadeh S.Solid lipid nanoparticles and nanostructured lipid carriers in oral cancer drug delivery..J Drug Deliv Sci Technol2020;55:101458

[83] Bayón-Cordero L,Arana L.Application of solid lipid nanoparticles to improve the efficiency of anticancer drugs..Nanomaterials2019;9:474 PMCID:PMC6474076

[84] Abdelaziz HM,Elzoghby AO.Kesharwani P.Chapter 5 - solid lipid nanoparticle-based drug delivery for lung cancer..Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer.2019;Academic Press95-121

[85] Rajabi M.Lipid nanoparticles and their application in nanomedicine..Curr Pharm Biotechnol2016;17:662-72

[86] Mihai MM,Călugăreanu A.Ficai A.Chapter 11 - Recent advances in diagnosis and therapy of skin cancers through nanotechnological approaches..Nanostructures for Cancer Therapy.2017;Elsevier285-306

[87] Trapani A,Tripodo G.Solid lipid nanoparticles made of self-emulsifying lipids for efficient encapsulation of hydrophilic substances. AIP Conference Proceedings 2145, 20004.2019;AIP Publishing LLC

[88] Dumont C,Fessi H,Jannin V.In-vitro evaluation of solid lipid nanoparticles: Ability to encapsulate, release and ensure effective protection of peptides in the gastrointestinal tract..Int J Pharm2019;565:409-18

[89] Oner E,Kantarci AG.A promising approach to develop nanostructured lipid carriers from solid lipid nanoparticles: preparation, characterization, cytotoxicity and nucleic acid binding ability..Pharm Dev Technol2020;25:936-48

[90] Rajpoot K.Oral delivery of pH-responsive alginate microbeads incorporating folic acid-grafted solid lipid nanoparticles exhibits enhanced targeting effect against colorectal cancer: a dual-targeted approach..Int J Biol Macromol2020;151:830-44

[91] Das Gupta S.Tocopherols in cancer: an update..Mol Nutr Food Res2016;60:1354-63 PMCID:PMC4899293

[92] Affram KO,Ofori E.Cytotoxic effects of gemcitabine-loaded solid lipid nanoparticles in pancreatic cancer cells..J Drug Deliv Sci Technol2020;55:101374 PMCID:PMC6941746

[93] Oliveira MS,Pattni B.Solid lipid nanoparticles co-loaded with doxorubicin and α-tocopherol succinate are effective against drug-resistant cancer cells in monolayer and 3-D spheroid cancer cell models..Int J Pharm2016;512:292-300

[94] Jiang T,Sun W.Doxorubicin encapsulated in TPGS-modified 2D-nanodisks overcomes multidrug resistance..Chem A Eur J2020;26:2470-7

[95] Tang J,Ren J.Solid lipid nanoparticles with TPGS and brij 78: a co-delivery vehicle of cur and piperine for reversing P-Glycoprotein-Mediated multidrug resistance in vitro..Oncol Lett2017;13:389-95 PMCID:PMC5245101

[96] Garg NK,Jain A.Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics..Colloids Surf B Biointerfaces2016;146:114-26

[97] Wang F,Liu B,Li C.Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer..Biomed Pharmacother2017;86:595-604

[98] Zheng G,Yang B,Li Y.Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo..Biomed Pharmacother2019;116:109006

[99] Pedrosa P,Ferreira-Silva M.Targeting cancer resistance via multifunctional gold nanoparticles..Int J Mol Sci2019;20:5510 PMCID:PMC6861975

[100] Rathinaraj P,Prasad NR.Folate-gold-bilirubin nanoconjugate induces apoptotic death in multidrug-resistant oral carcinoma cells..Eur J Drug Metab Pharmacokinet2020;45:285-96

[101] Kumon K,Kuroda S.Abstract 3617: Trastuzumab-conjugated gold nanoparticles as novel HER2-targeted therapeutics against trastuzumab-resistant gastric cancer..Cancer Res2019;79:3617

[102] Deng R,Yu H.Multifunctional gold nanoparticles overcome microRNA regulatory network mediated-multidrug resistant leukemia..Sci. Rep2019;9:1-11 PMCID:PMC6440980

[103] Huai Y,Xiong X,Bhattacharya R.Gold nanoparticles sensitize pancreatic cancer cells to gemcitabine..Cell Stress2019;3:267-79 PMCID:PMC6702449

[104] Talamantez-Lyburn S,Hondrogiannis N.Gold nanoparticles loaded with cullin-5 DNA increase sensitivity to 17-AAG in cullin-5 deficient breast cancer cells..Int J Pharm2019;564:281-92 PMCID:PMC6584956

[105] Gopisetty MK,Igaz N.Endoplasmic reticulum stress: major player in size-dependent inhibition of P-glycoprotein by silver nanoparticles in multidrug-resistant breast cancer cells..J Nanobiotechnol2019;17:9 PMCID:PMC6341731

[106] Ramezani T,Baharara J,Namvar F.Sensitization of resistance ovarian cancer cells to cisplatin by biogenic synthesized silver nanoparticles through p53 activation..Iran J Pharm Res2019;18:222-31 PMCID:PMC6487401

[107] Kovács D,Igaz N.Silver nanoparticles modulate ABC transporter activity and enhance chemotherapy in multidrug resistant cancer..Nanomedicine Nanotechnol Biol Med2016;12:601-10

[108] Wang Y,Wang S,Tang R.In vivo dual-targeted chemotherapy of drug resistant cancer by rationally designed nanocarrier..Biomaterials2016;75:71-81

[109] Fernández M,Chudasama V.Advances in targeting the folate receptor in the treatment/imaging of cancers..Chem Sci2018;9:790-810 PMCID:PMC5890329

[110] Cho MH,Lee JH.Magnetic tandem apoptosis for overcoming multidrug-resistant cancer..Nano Lett2016;16:7455-60

[111] Truffi M,Sorrentino L.Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells..Sci Rep2018;8:1-11 PMCID:PMC5920071

[112] Miller-Kleinhenz J,Qian W.Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer..Biomaterials2018;152:47-62 PMCID:PMC5831137

[113] Liu E,Cui H.Tat-functionalized Ag-Fe3O4 nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery..Acta Pharm Sin B2018;8:956-68 PMCID:PMC6251815

[114] Weng H,Zhang J.TAT peptide-modified cisplatin-loaded iron oxide nanoparticles for reversing cisplatin-resistant nasopharyngeal carcinoma..Biochem Biophys Res Commun2019;511:597-603

[115] Ma P,Yu C.Enhanced cisplatin chemotherapy by iron oxide nanocarrier-mediated generation of highly toxic reactive oxygen species..Nano Lett2017;17:928-37

[116] Guo S,Jiang Q.Dihydroartemisinin-loaded magnetic nanoparticles for enhanced chemodynamic therapy..Front Pharmacol2020;11:1-11 PMCID:PMC7076125

[117] Yen TY,Lin G.Catalase-functionalized iron oxide nanoparticles reverse hypoxia-induced chemotherapeutic resistance..Adv Healthc Mater2019;8:1-8 PMCID:PMC6919328

[118] Roleira FM,Varela CL.Plant derived and dietary phenolic antioxidants: anticancer properties..Food Chem2015;183:235-58

[119] Wang J,Li F.A multifunctional poly(curcumin) nanomedicine for dual-modal targeted delivery, intracellular responsive release, dual-drug treatment and imaging of multidrug resistant cancer cells..J Mater Chem B2016;4:2954-62 PMCID:PMC4847526

[120] Keskin T,Gunduz U.Folic acid functionalized PEG coated magnetic nanoparticles for targeting anti-cancer drug delivery: preparation, characterization and cytotoxicity on Doxorubicin, Zoledronic acid and Paclitaxel resistant MCF-7 breast cancer cell lines..Inorg Nano-Metal Chem2018;48:150-9

[121] Song W,Gregory DA,Cai Z.Magnetic alginate/chitosan nanoparticles for targeted delivery of curcumin into human breast cancer cells..Nanomaterials2018;8:907 PMCID:PMC6267575

[122] Chen S,Liu E.Curcumin/sunitinib co-loaded BSA-stabilized SPIOs for synergistic combination therapy for breast cancer..J Mater Chem B2017;5:4060-72

[123] Rastegar R,Khoobi M.Evaluation of a novel biocompatible magnetic nanomedicine based on beta-cyclodextrin, loaded doxorubicin-curcumin for overcoming chemoresistance in breast cancer..Artif Cells Nanomedicine Biotechnol2018;46:207-16

[124] Daglioglu C.Enhancing tumor cell response to multidrug resistance with ph-sensitive quercetin and doxorubicin conjugated multifunctional nanoparticles..Colloids Surfaces B Biointerfaces2017;156:175-85

[125] Wang D,Li X.Magnetic and pH dual-responsive nanoparticles for synergistic drug-resistant breast cancer chemo/photodynamic therapy..Int J Nanomedicine2019;14:7665-79 PMCID:PMC6756767

[126] Shenderova OA,Brenner D.Gruen DM,Vul AY.Carbon family at the nanoscale BT - synthesis, properties and applications of ultrananocrystalline diamond..2005;NetherlandsSpringer1-14

[127] Heimann RB,Koga Y.Carbon allotropes: a suggested classification scheme based on valence orbital hybridization..Carbon N Y1997;35:1654-8

[128] Li D,Fan Y.Ultrasound-enhanced fluorescence imaging and chemotherapy of multidrug-resistant tumors using multifunctional dendrimer/carbon dot nanohybrids..Bioact2020;6:729-39 PMCID:PMC7519212

[129] Li D,Shen M,Shi X.Design of dual drug-loaded dendrimer/carbon dot nanohybrids for fluorescence imaging and enhanced chemotherapy of cancer cells..J Mater Chem B2019;7:277-85

[130] Patel KD,Kim HW.Carbon-based nanomaterials as an emerging platform for theranostics..Mater Horizons2019;6:434-69

[131] Mehra NK.Interactions between carbon nanotubes and bioactives: a drug delivery perspective..Drug Discov Today2016;21:585-97

[132] Maiti D,Mou X.Carbon-based nanomaterials for biomedical applications: a recent study..Front Pharmacol2019;9:1401 PMCID:PMC6421398

[133] Bianco A, Pantarotto D, Kostarelos K, Prato M. Non-covalent complexes comprising carbon nanotubes. 2010. Available from: https://patents.google.com/patent/US7858648. [Last accessed on 18 Nov 2020]

[134] Iannazzo D,Celesti C.A smart nanovector for cancer targeted drug delivery based on graphene quantum dots..Nanomaterials2019;9:282 PMCID:PMC6409783

[135] Tian L,Li H.Hollow mesoporous carbon modified with cRGD peptide nanoplatform for targeted drug delivery and chemo-photothermal therapy of prostatic carcinoma..Colloids Surfaces A Physicochem Eng Asp2019;570:386-95

[136] Mahajan S,Kuche K.Functionalized carbon nanotubes as emerging delivery system for the treatment of cancer..Int J Pharm2018;548:540-58

[137] Loh KP,Chiu GNC.Clinical applications of carbon nanomaterials in diagnostics and therapy..Adv Mater2018;30:1802368

[138] Taghavi S,Abnous K.Polyethylenimine-functionalized carbon nanotubes tagged with AS1411 aptamer for combination gene and drug delivery into human gastric cancer cells..Int J Pharm2017;516:301-12

[139] Fan K,Fan L.In vivo guiding nitrogen-doped carbon nanozyme for tumor catalytic therapy..Nat Commun2018;9:1440 PMCID:PMC5897348

[140] Fan K,Pan Y.Magnetoferritin nanoparticles for targeting and visualizing tumour tissues..Nat. Nanotechnol2012;7:459-64

[141] Alexander A,Yadav P.Chapter 17 - Targeted delivery through carbon nanomaterials: applications in bioactive delivery systems Edited by Singh MR, Singh D, Kanwar JR, Chauhan NSBT-A and A in the D of NC for B and BA.2020;Academic Press509-24

[142] Pei X,Gan Z.PEGylated nano-graphene oxide as a nanocarrier for delivering mixed anticancer drugs to improve anticancer activity..Sci Rep2020;10:1-15 PMCID:PMC7026168

[143] Qian R,Zhong J.Multifunctional nano-graphene based nanocomposites for multimodal imaging guided combined radioisotope therapy and chemotherapy..Carbon N Y2019;149:55-62

[144] Hong G,Antaris AL.Carbon nanomaterials for biological imaging and nanomedicinal therapy..Chem Rev2015;115:10816-906

[145] Costa PM,Wang JTW.Functionalized carbon nanotubes: From intracellular uptake and cell-related toxicity to systemic brain delivery..J Control Release2016;241:200-19

[146] Kim SW,Kim SH.Covalent, non-covalent, encapsulated nanodrug regulate the fate of intra- and extracellular trafficking: impact on cancer and normal cells..Sci Rep2017;7:6454 PMCID:PMC5526881

[147] Ali MS,Fahmy RH.Nanodiamonds: minuscule gems that ferry antineoplastic drugs to resistant tumors..Int J Pharm2019;558:165-76

[148] Curcio M,Saletta F.Functionalized carbon nanostructures versus drug resistance: promising scenarios in cancer treatment..Molecules2020;25:2102 PMCID:PMC7249046

[149] Hosnedlova B,Fernandez C.Carbon nanomaterials for targeted cancer therapy drugs: a critical review..Chem Rec2019;19:502-22

[150] Mehra NK,Nahar M.Carbon nanomaterials in oncology: an expanding horizon..Drug Discov Today2018;23:1016-25

[151] de Melo-Diogo D,Alves CG,Louro RO.Functionalization of graphene family nanomaterials for application in cancer therapy..Colloids Surf B Biointerfaces2018;171:260-75

[152] Liu J,Zhang T.Graphene-based nanomaterials and their potentials in advanced drug delivery and cancer therapy..J Control Release2018;286:64-73

[153] Jiang B,Lin Z,Shen X.Recent advances in carbon nanomaterials for cancer phototherapy..Chem A Eur J2019;25:3993-4004

[154] Mohajeri M,Sahebkar A.Biomedical applications of carbon nanomaterials: Drug and gene delivery potentials..J. Cell Physiol2019;234:298-319

[155] Chen D,Zhu K.Theranostic applications of carbon nanomaterials in cancer: focus on imaging and cargo delivery..J Control Release2015;210:230-45

[156] Dong X,Wang X.An innovative MWCNTs/DOX/TC nanosystem for chemo-photothermal combination therapy of cancer..Nanomed Nanotechnol Biol Med2017;13:2271-80

[157] Meng Y,Li C.Photothermal combined gene therapy achieved by polyethyleneimine-grafted oxidized mesoporous carbon nanospheres..Biomaterials2016;100:134-42

[158] Mohapatra S,Das RK,Ghosh SK.Highly hydrophilic luminescent magnetic mesoporous carbon nanospheres for controlled release of anticancer drug and multimodal imaging..Langmuir2016;32:1611-20

[159] Zhao N,Zhao X.Polycation-carbon nanohybrids with superior rough hollow morphology for the NIR-II responsive multimodal therapy..ACS Appl Mater Interfaces2020;12:11341-52

[160] Wang K,Meng Y.Specific aptamer-conjugated mesoporous silica-carbon nanoparticles for HER2-targeted chemo-photothermal combined therapy..Acta Biomater2015;16:196-205

[161] Li F,Zhang Z,Guo S.A chemo/photo- co-therapeutic system for enhanced multidrug resistant cancer treatment using multifunctional mesoporous carbon nanoparticles coated with poly (curcumin-dithiodipropionic acid)..Carbon N Y2017;122:524-37

[162] Tu X,Cao Y.Efficient cancer ablation by combined photothermal and enhanced chemo-therapy based on carbon nanoparticles/doxorubicin@SiO2 nanocomposites..Carbon N Y2016;97:35-44

[163] Feng T,An G,Zhao Y.Charge-convertible carbon dots for imaging-guided drug delivery with enhanced in vivo cancer therapeutic efficiency..ACS Nano2016;10:4410-20

[164] Feng T,Zhao Y.Carbon-dot-mediated co-administration of chemotherapeutic agents for reversing cisplatin resistance in cancer therapy..ChemNanoMat2018;4:801-6

[165] Ren W,Liao Y.Near-infrared fluorescent carbon dots encapsulated liposomes as multifunctional nano-carrier and tracer of the anticancer agent cinobufagin in vivo and in vitro..Colloids Surfaces B Biointerfaces2019;174:384-92

[166] Chiu SH,Girma WM.Rapid fabrication of carbon quantum dots as multifunctional nanovehicles for dual-modal targeted imaging and chemotherapy..Acta Biomater2016;46:151-64

[167] Thakur M,Pandey S.Milk-derived multi-fluorescent graphene quantum dot-based cancer theranostic system..Mater Sci Eng C2016;67:468-77

[168] Sui X,Wang C.Graphene quantum dots enhance anticancer activity of cisplatin via increasing its cellular and nuclear uptake..Nanomed Nanotechnol Biol Med2016;12:1997-2006

[169] Shenderova OA.Nanodiamonds. Springer Handbook of Nanomaterials.2013;Berlin HeidelbergSpringer263-300

[170] Varin RA,Wronski ZS.Carbons and Nanocarbons BT - Nanomaterials for Solid State Hydrogen Storage.2009;USSpringer291-320

[171] Yu Y,Liu M,Tei T.Amphipathic nanodiamond supraparticles for anticancer drug loading and delivery..ACS Appl Mater Interfaces2019;11:18978-87

[172] Zhu H,Hussain A.Nanodiamond mediated co-delivery of doxorubicin and malaridine to maximize synergistic anti-tumor effects on multi-drug resistant MCF-7/ADR cells..J Mater Chem B2017;5:3531-40

[173] Lam ATN,Ly NH.Electrostatically self-assembled quinazoline-based anticancer drugs on negatively-charged nanodiamonds for overcoming the chemoresistances in lung cancer cells..Biochip J2018;12:163-71

[174] Chan MS,Leung HM.Cancer-cell-specific mitochondria-targeted drug delivery by dual-ligand-functionalized nanodiamonds circumvent drug resistance..ACS Appl Mater Interfaces2017;9:11780-9

[175] Li TF,Zhang Q.Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma..Biomaterials2018;181:35-52

[176] Li TF,Li K.Doxorubicin-polyglycerol-nanodiamond composites stimulate glioblastoma cell immunogenicity through activation of autophagy..Acta Biomater2019;86:381-94

[177] Chen Z,Li TF.Doxorubicin conjugated with nanodiamonds and in free form commit glioblastoma cells to heterodromous fates..Nanomedicine2019;14:335-51

[178] Chen Z,Li K.Doxorubicin-polyglycerol-nanodiamond conjugates disrupt STAT3/IL-6-mediated reciprocal activation loop between glioblastoma cells and astrocytes..J Control Release2020;320:469-83

[179] Yuan SJ,Wang C.Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer..J Nanobiotechnol2019;17:110 PMCID:PMC6798483

[180] Tiwari H,Pal M.Functionalized graphene oxide as a nanocarrier for dual drug delivery applications: the synergistic effect of quercetin and gefitinib against ovarian cancer cells..Colloids Surf B Biointerfaces2019;178:452-9

[181] Tran TH,Pham TT.Development of a graphene oxide nanocarrier for dual-drug chemo-phototherapy to overcome drug resistance in cancer..ACS Appl Mater Interfaces2015;7:28647-55

[182] Thapa RK,Jeong JH,Yong CS.Graphene oxide-wrapped PEGylated liquid crystalline nanoparticles for effective chemo-photothermal therapy of metastatic prostate cancer cells..Colloids Surf B Biointerfaces2016;143:271-7

[183] Huang C,Hou Z,Li Z.Tailored graphene oxide-doxorubicin nanovehicles via near-infrared dye-lactobionic acid conjugates for chemo-photothermal therapy..J. Colloid Interface Sci2019;545:172-83

[184] Han C,Ma T.Hypericin-functionalized graphene oxide for enhanced mitochondria-targeting and synergistic anticancer effect..Acta Biomater2018;77:268-81

[185] Guo L,Wu H.Prostate cancer targeted multifunctionalized graphene oxide for magnetic resonance imaging and drug delivery..Carbon N Y2016;107:87-99

[186] Luo Y,Li H,Du D.Hyaluronic acid-modified multifunctional Q-graphene for targeted killing of drug-resistant lung cancer cells..ACS Appl Mater Interfaces2016;8:4048-55

[187] Chatterjee N,Kim S,Choi J.Diameter size and aspect ratio as critical determinants of uptake, stress response, global metabolomics and epigenetic alterations in multi-wall carbon nanotubes..Carbon N Y2016;108:529-40

[188] Donaldson K.Nanotoxicology: new insights into nanotubes..Nature Nanotechnol2009;4:708-10

[189] Dong X,Wang X.Simultaneous monitoring of the drug release and antitumor effect of a novel drug delivery system-MWCNTs/DOX/TC..Drug Deliv2017;24:143-51

[190] Raza K,Kiran C.Conjugation of docetaxel with multiwalled carbon nanotubes and codelivery with piperine: Implications on pharmacokinetic profile and anticancer activity..Mol Pharm2016;13:2423-32

[191] Zhang M,Wu F,Chi C.Magnetic and fluorescent carbon nanotubes for dual modal imaging and photothermal and chemo-therapy of cancer cells in living mice..Carbon N Y2017;123:70-83

[192] Guven A,Lewis MT.Cisplatin@US-tube carbon nanocapsules for enhanced chemotherapeutic delivery..Biomaterials2012;33:1455-61 PMCID:PMC3417041

[193] Guven A,Hilsenbeck SG.Carbon nanotube capsules enhance the in vivo efficacy of cisplatin..Acta Biomater2017;58:466-78 PMCID:PMC6344128

[194] Ghosh M.Doxorubicin loaded 17β-estradiol based SWNT dispersions for target specific killing of cancer cells..Colloids Surfaces B Biointerfaces2016;142:367-76

[195] Razzazan A,Kazemi B.In vivo drug delivery of gemcitabine with PEGylated single-walled carbon nanotubes..Mater Sci Eng C2016;62:614-25

[196] Li Y,Long M,Chen Z.Nitroimidazole derivative incorporated liposomes for hypoxia-triggered drug delivery and enhanced therapeutic efficacy in patient-derived tumor xenografts..Acta Biomater2019;83:334-48